Navigation Links
Pitt study suggests craving hinders comprehension without your realizing it
Date:12/7/2009

PITTSBURGHA new University of Pittsburgh study reveals that craving a cigarette while performing a cognitive task not only increases the chances of a person's mind wandering, but also makes that person less likely to notice when his or her mind has wandered.

The paper, titled "Out for a Smoke: The Impact of Cigarette Craving on Zoning Out During Reading," provides the first evidence that craving disrupts an individual's meta-awareness, the ability to periodically appraise one's own thoughts.

The research is published in the January issue of Psychological Science.

Pitt professor of psychology Michael Sayette and colleagues Erik Reichle, associate professor and chair of Pitt's cognitive program in psychology, and Jonathan Schooler, professor of psychology at the University of California, Santa Barbara, recruited 44 male and female heavy smokers to take part in the study. All smoked nearly a pack a day and refrained from smoking for at least six hours before arriving at the lab.

Participants were assigned at random to either a crave-condition or low-crave group. Those in the latter group were permitted to smoke throughout the study; members of the crave-condition group had to abstain. Participants were asked to read as many as 34 pages of Tolstoy's War and Peace from a computer screen. If they caught themselves zoning out, they pressed a key labeled ZO. Every few minutes, a tone sounded, and they were asked via the computer, "Were you zoning out?" to which they responded by pressing a "Yes" or "No" key. After 30 minutes, a reading comprehension test was administered.

Although both groups were prompted a similar number of times, the people craving cigarettes acknowledged more mind-wandering episodesthree times as many, in fact as those in the low-crave group. But as far as independently recognizing (meta-awareness) that they were zoning out, those who were craving were no more likely to do so than the other group. Participants in the craving group had at least three times as many opportunities to catch themselves zoning outbut they did not. They were impaired in their ability to notice their own mind-wandering episodes.

"Researchers have known for a while that cigarette craving can interfere with our powers of concentration," Sayette said. "But, similar to what we found in a previous study about the impaired concentration of people who drank, this 'double whammy' (i.e., more zoneouts that take longer to recognize) may explain why craving often disrupts efforts to exercise self-controla process requiring the ability to become aware of your current state in order to regulate it."

This observationthat craving may impair sustained attention and reduce meta-awarenesscould be of interest to those who study workplace accidents, where smokers must refrain. It also offers a new way to examine factors that interfere with learning among college students who smoke and must abstain for extended periods during classes.


'/>"/>

Contact: Sharon Blake
blake@pitt.edu
412-624-4364
University of Pittsburgh
Source:Eurekalert

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... As part of their 2015 end of year ... Table Foundation (MDRTF), has gifted $10,000 to University of Chicago to support ovarian cancer ... Cundiff. , “We are honored to support a promising young investigator from Dr. Lengyel’s ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... World Molecular Imaging Congress (WMIC), will be held in New York City, NY ... “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals a ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Early this week, ... and raise awareness of Nestlé KITKAT as the first global confectionery brand sourced from ... cocoa farmers and the quality of their product, through activities that focus on better ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
(Date:2/10/2016)... Walton Beach, Florida (PRWEB) , ... February 10, ... ... the innovative weather-forecasting company is unveiling its revolutionary new 2.0 version at the ... platform, MetLoop has “put the power of the world's most advanced weather technology ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... fourth quarter and full year ended December 31, 2015. ... was a transformational year for Vanda with the continued ... market approval of HETLIOZ for Non-24," said Mihael H. ... Fanapt to our U.S. product portfolio builds on this ...
(Date:2/10/2016)... , February 10, 2016 ... Analyzers (Liquid & Gas), and Spectroscopy Market by Industry (Oil ... Beverage, Pulp & Paper, Metal & Mining, and Others), ... MarketsandMarkets, the global market is expected to grow to ... of 8.6% between 2015 and 2020. Browse ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
Breaking Medicine Technology: